抑制S1PR3通过抑制NF-κB和改善线粒体氧化酸化来保护LPS诱导的ARDS
Junnan Peng1, Rui Tang1, Jing He1
1Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, No.76 Linjiang Road, Yuzhong District, Chongqing, 400010, People's Republic of China.
Journal of translational medicine
|June 5, 2024
概括
抑制神素-1-酸盐受体3 (S1PR3) 减少炎症并保护急性呼吸困扰综合征 (ARDS) 中的内皮屏障. 这一发现凸显了S1PR3作为ARDS治疗的潜在治疗点.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 急性呼吸困扰综合征 (ARDS) 的特征是炎症和内皮屏障功能障碍.
- 氨酸-1-酸盐受体3 (S1PR3) 在炎症和内皮细胞完整性中起作用.
- 对于S1PR3在ARDS病原体中的特定作用尚不清楚.
研究的目的:
- 在ARDS的实验模型中研究S1PR3的功能.
- 为了确定S1PR3抑制是否提供对ARDS相关炎症和内皮屏障损伤的保护作用.
主要方法:
- 使用脂聚糖 (LPS) 诱导的小鼠ARDS模型和LPS刺激的内皮细胞 (ECs).
- 采用选择性S1PR3抑制剂 (TY-52156),腺相关病毒 (体内) 和小干扰RNA (体内) 来抑制S1PR3.
- 分析了促炎性细胞因子的表达,内皮屏障完整性,NF-κB通路激活和线粒体氧化酸化.
主要成果:
- 在LPS诱导的ARDS肺组织中,S1PR3表达被上调.
- 通过抑制促炎性细胞因子和恢复内皮屏障功能,S1PR3抑制减轻了炎症.
- 通过抑制NF-κB通路并增强线粒体氧化酸化,抑制S1PR3保护ARDS.
结论:
- 抑制S1PR3表明对LPS诱导的ARDS具有显著的保护作用.
- 准S1PR3可以抑制肺炎并促进内皮壁的完整性.
- S1PR3代表了对管理ARDS的有前途的治疗点.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...